← Oncology Approval Tracker

FDA DECISION ·

Ogsiveo

nirogacestat · SpringWorks Therapeutics

FDA approvalNew therapyDesmoid tumors
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

For adults with progressing desmoid tumors that require systemic therapy.

LAMPGEN ANALYSIS

Why it matters

FDA approved the first treatment specifically for desmoid tumors, a rare locally aggressive tumor.

What research teams should watch

Verify documented progression and the need for systemic treatment. Build symptom and treatment-toxicity assessments into follow-up.

PRIMARY RECORDS

Sources